Michaela Theilmann
A5025277130- Global Public Health Policies and Epidemiology
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Chronic Disease Management Strategies
- Cardiovascular Health and Risk Factors
- Diabetes Management and Education
- Blood Pressure and Hypertension Studies
- Health Systems, Economic Evaluations, Quality of Life
- Health disparities and outcomes
- Child Nutrition and Water Access
- Health Promotion and Cardiovascular Prevention
- Obesity, Physical Activity, Diet
- Lipoproteins and Cardiovascular Health
- Healthcare Systems and Reforms
- Primary Care and Health Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Birth, Development, and Health
- Cardiac Health and Mental Health
- Global Health Care Issues
- Antiplatelet Therapy and Cardiovascular Diseases
- HIV/AIDS Impact and Responses
- Vaccine Coverage and Hesitancy
- Traffic and Road Safety
- Smoking Behavior and Cessation
- Sodium Intake and Health
- Immune responses and vaccinations
Washington University in St. Louis
2024
Heidelberg University
2019-2024
University Hospital Heidelberg
2019-2024
Technical University of Munich
2023-2024
Universidade Federal de Minas Gerais
2024
Brigham and Women's Hospital
2024
Heidelberg University
2023
Institute for Advanced Study
2023
Center for Evaluation and Development
2019
University of Göttingen
2018
Understanding how diabetes and hypertension prevalence varies within a country as large India is essential for targeting of prevention, screening, treatment services. However, to our knowledge there has been no prior nationally representative study these conditions guide the design effective policies.To determine in India, its variation by state, rural vs urban location, individual-level sociodemographic characteristics.This was cross-sectional, representative, population-based carried out...
Approximately 80% of the 463 million adults worldwide with diabetes live in low- and middle-income countries (LMICs). A major obstacle to designing evidence-based policies improve outcomes LMICs is limited nationally representative data on current patterns treatment coverage. The objectives this study are (1) estimate proportion who receive coverage recommended pharmacological non-pharmacological (2) describe country-level individual-level characteristics that associated treatment.We...
OBJECTIVEDiabetes is a rapidly growing health problem in low- and middle-income countries (LMICs), but empirical data on its prevalence relationship to socioeconomic status are scarce. We estimated diabetes the subset with undiagnosed 29 LMICs evaluated of education, household wealth, BMI risk.
<h3>Importance</h3> The World Health Organization is developing a global strategy to eliminate cervical cancer, with goals for screening prevalence among women aged 30 through 49 years. However, evidence on levels of cancer in low- and middle-income countries (LMICs) sparse. <h3>Objective</h3> To determine lifetime LMICs its variation across within world regions countries. <h3>Design, Setting, Participants</h3> Analysis cross-sectional nationally representative household surveys carried out...
Background Cardiovascular disease (CVD) is the leading cause of mortality in India. Yet, evidence on CVD risk India's population limited. To inform health system planning and effective targeting interventions, this study aimed to determine how risk—and factors that risk—varies among states India, by rural–urban location, individual-level sociodemographic characteristics. Methods findings We used 2 large household surveys carried out between 2012 2014, which included a sample 797,540 adults...
In the prevention of cardiovascular disease, a WHO target is that at least 50% eligible people use statins. Robust evidence needed to monitor progress towards this in low-income and middle-income countries (LMICs), where most disease deaths occur. The objectives study were benchmark statin LMICs investigate country-level individual-level characteristics associated with use.We did cross-sectional analysis pooled, data from nationally representative health surveys done 41 between 2013 2019....
To determine the prevalence and frequency of using any tobacco product each a detailed set products, how use vary across countries, world regions, World Bank country income groups, socioeconomic demographic gradients within countries.
Population-based studies on anaemia in India have mostly focused women and children, with men receiving much less attention despite anaemia's adverse effect health, wellbeing, economic productivity. This study aimed to determine the national prevalence of among India; how varies across states districts by sociodemographic characteristics; whether geographical variation is similar that inform reduction efforts for should be coupled existing women.In this cross-sectional study, we analysed...
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population's median 10-year predicted CVD risk, including its variation within by socio-demographic characteristics, (2) prevalence of self-reported blood pressure (BP) medication use among those with without an indication for such as per World Health Organization (WHO) guidelines.
Diabetes prevalence is increasing rapidly in rural areas of low- and middle-income countries (LMICs), but there are limited data on the performance health systems delivering equitable effective care to populations. We therefore assessed rural-urban differences diabetes control LMICs.We pooled individual-level from nationally representative surveys 42 countries. used Poisson regression models estimate age-adjusted proportion individuals with versus urban achieving measures for diagnosis,...
As the prevalence of hypercholesterolemia is increasing in low- and middle-income countries (LMICs), detailed evidence urgently needed to guide response health systems this epidemic. This study sought quantify unmet need for care among adults 35 LMICs.We pooled individual-level data from 129,040 respondents aged 15 years older nationally representative surveys conducted between 2009 2018. Hypercholesterolemia was quantified using cascade analyses sample by region, country income group,...
Given the increasing prevalence of diabetes in low-income and middle-income countries (LMICs), we aimed to estimate health cost implications achieving different targets for diagnosis, treatment, control its associated cardiovascular risk factors among LMICs.
Alcohol is a leading risk factor for over 200 conditions and an important contributor to socioeconomic health inequalities. However, little known about the associations between individuals' circumstances alcohol consumption, especially heavy episodic drinking (HED; ≥5 drinks on one occasion) in low-income or middle-income countries. We investigated association individual household level status, habits these settings.
BackgroundTesting for the risk factors of cardiovascular disease, which include hypertension, diabetes, and hypercholesterolaemia, is important timely effective management. Yet few studies have quantified analysed testing in low-income middle-income countries (LMICs) with respect to sociodemographic inequalities. We aimed address this knowledge gap.MethodsIn cross-sectional analysis, we pooled individual-level data non-pregnant adults aged 18 years or older from nationally representative...
Importance Aspirin is an effective and low-cost option for reducing atherosclerotic cardiovascular disease (CVD) events improving mortality rates among individuals with established CVD. To guide efforts to mitigate the global CVD burden, there a need understand current levels of aspirin use secondary prevention Objective report evaluate across low-, middle-, high-income countries. Design, Setting, Participants Cross-sectional analysis using pooled, individual participant data from nationally...
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally.1 In recent decades, a rising prevalence major CVD risk factors including diabetes, hypertension hyperlipidemia has been observed in many low- middle-income countries (LMICs) where was not previously considered health priority. As economic development drives urbanization changes lifestyles LMICs, this trend expected to continue.2–4 Although ∼80% deaths now occur LMICs,5 there are few data sources that allow...